CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma

BACKGROUND: Renal cell carcinoma (RCC) is the most common kidney cancer, accounting for approximately 80–90% of all primary kidney cancer. Treatment for patients with advanced RCC remains unsatisfactory. Rare cancer stem cells (CSCs) are proposed to be responsible for failure of current treatment. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Du-Chu, Liang, You-De, Peng, Liang, Wang, Yi-Ze, Ai, Chun-Zhi, Zhu, Xin-Xing, Yan, Ya-Wei, Saeed, Yasmeen, Yu, Bin, Huang, Jingying, Gao, Yuxin, Liu, Jiaqi, Jiang, Yi-Zhou, Liu, Min, Chen, Demeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686942/
https://www.ncbi.nlm.nih.gov/pubmed/29162985
http://dx.doi.org/10.1186/s12935-017-0473-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686942/
https://www.ncbi.nlm.nih.gov/pubmed/29162985
http://dx.doi.org/10.1186/s12935-017-0473-z

Ejemplares similares